Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Cash from Operations (2022 - 2025)

CervoMed's Cash from Operations history spans 9 years, with the latest figure at 6465210.0 for Q3 2025.

  • For Q3 2025, Cash from Operations fell 33.18% year-over-year to 6465210.0; the TTM value through Sep 2025 reached 24925182.0, down 126.21%, while the annual FY2024 figure was 16530827.0, 121.89% down from the prior year.
  • Cash from Operations for Q3 2025 was 6465210.0 at CervoMed, up from 6514695.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 6856778.0 in Q3 2022 and bottomed at 8050918.0 in Q4 2024.
  • The 4-year median for Cash from Operations is 2538454.0 (2023), against an average of 2895179.8.
  • The largest YoY upside for Cash from Operations was 68.67% in 2023 against a maximum downside of 266.55% in 2023.
  • A 4-year view of Cash from Operations shows it stood at 692530.0 in 2022, then tumbled by 266.55% to 2538454.0 in 2023, then tumbled by 217.16% to 8050918.0 in 2024, then increased by 19.7% to 6465210.0 in 2025.
  • Per Business Quant, the three most recent readings for CRVO's Cash from Operations are 6465210.0 (Q3 2025), 6514695.0 (Q2 2025), and 3894359.0 (Q1 2025).